Sodium Hydroxide → (+/-)-dihydro-3-[(1-carboxy-3-phenylpropyl)amino]-4-oxo-1,5-benzothiazepine-5(2H)-acetic acid
반응식
C([O:3][C:4]([CH:6]([NH:15][CH:16]1[C:22](=[O:23])[N:21]([CH2:24][C:25]([O:27]CC)=[O:26])[CH:20]2[CH2:30][CH:31]=[CH:32][CH:33]=[C:19]2[S:18][CH2:17]1)[CH2:7][CH2:8][C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1)=[O:5])C.[OH-].[Na+]>>[C:4]([CH:6]([NH:15][CH:16]1[C:22](=[O:23])[N:21]([CH2:24][C:25]([OH:27])=[O:26])[CH:20]2[CH2:30][CH:31]=[CH:32][CH:33]=[C:19]2[S:18][CH2:17]1)[CH2:7][CH2:8][C:9]1[CH:10]=[CH:11][CH:12]=[CH:13][CH:14]=1)([OH:5])=[O:3]참가 물질
3
실험 절차
The diethyl ester product from part (f) is treated with sodium hydroxide according to the procedure of Example 1(h) to yield (±)-dihydro-3-[(1-carboxy-3-phenylpropyl)amino]-4-oxo-1,5-benzothiazepine-5(2H)-acetic acid.
출처 및 근거
- ORD 기록
- ord-003f582099f14af180bd63243f03c87c
- 출처 데이터셋
- uspto-grants-1987_12
- 특허 번호
- US04711884
반응 노트
불러오는 중…